Atom | Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)

Funder: National Institutes of Health

Due Dates: April 7, 2025 (Open Date) | May 7, 2025 | September 7, 2025 | January 7, 2026 | February 18, 2026 (Final Receipt Date)

Funding Amounts: Budgets are not limited; project period up to 5 years; typical R01 scale.

Summary: Supports research on how HIV-induced immunometabolic changes in cART-suppressed individuals increase risk for TB or HBV, aiming to inform new biomarkers and therapies.

Key Information: Clinical trials are not allowed; applications must include preliminary data; companion R21 opportunity available.

Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)

Sign in to see full grant listing